Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Table 1 reports appropriateness rates to AFT alone or in combination with vitamin D (Table 1, parts A and B), and 1-year adherence rates to appropriate treatments (Table 1, parts C and D) by comparing pre: and post-intervention phases.
Source: AFT appropriate initiation and 1-year adherence. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Observational study.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
The PROMOTER-II (PRogetto Osteoporosi Multidisciplinare Ospedali e TERritorio: secondary prevention) study is a multicenter pre: and post-intervention observational study aimed at improving secondary prevention in subjects who suffered major osteoporotic FFs in the province of Pavia [], which encompasses 536,406 citizens, with 49.1% aged 50 years and more.
Source: Methods.
Eligible participants were men and women aged ≥ 50 years old, residents of the province of Pavia, who were admitted due to low-energy major FF (i.e., hip, vertebral, humerus, or wrist) to the Emergency Department (ED) or the Trauma and Orthopedic Units of Pavia, Stradella, Vigevano, and Voghera hospitals.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Effectiveness of an integrated hospital-community care pathway for fragility fractures’ secondary prevention: the PROMOTER-II study
Observational study · Archives of Osteoporosis · 2025
Original publication title
Effectiveness of an integrated hospital-community care pathway for fragility fractures’ secondary prevention: the PROMOTER-II study
© The Author(s) 2025
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
Evaluate the effectiveness of an integrated healthcare pathway (IHCP) on appropriateness and adherence to anti-fracture treatment (AFT) in adults aged ≥ 50 years, hospitalized due to fragility fracture (FF). Re-fractures and mortality rates were explored as secondary outcomes.
Source: PurposeAbstract: What methods does the paper describe?
Subjects aged 50 years and more, resident in the province of Pavia, Italy, were enrolled at the time of hospital admission due to major FF, in the period 2016 to 2018 and 2019 to 2020 before and after the implementation of the IHCP, respectively. Data were extracted from the administrative database of the Health Protection Agency of Pavia, starting from the index event and until 24 months. Data analyses were conducted for the primary and secondary outcomes. Univariate and multivariate Cox regression models were fitted.
Source: MethodsAbstract: Summary
As the global population ages, osteoporosis and fragility fractures (FF) are emerging health concerns worldwide. This study assesses the effectiveness of an integrated hospital-community pathway in improving prescription and adherence to anti-fracture treatment. Additionally, it analyzes the re-fracture rate and mortality at a 24-month follow-up from an index FF.
Source: SummaryAbstract: Results
Among 9186 participants (74.7% women), aged 78 years, 12.7% initiated an AFT, and half of them (6.3%) within 6 months after the index FF. Comparing pre: and post: IHCP implementation phases, the appropriateness of AFT initiation increased in subjects with index humerus/wrist FF, oral AFT prescription decreased, while subcutaneous or intravenous treatments increased (p < 0.001). Total adherence to AFT slightly increased. The re-fracture rate was 5.2 per 100 person/year, with age, IHCP implementation, and hip FF associated with a higher likelihood of refracture.
The mortality rate was 13.4 per 100 person/year, with age, male gender, IHCP, and hip fracture as independent risk factors. Appropriate AFT significantly reduced mortality compared to no treatment (HR 0.55), with one-year adherence showing the strongest benefit (HR 0.18). Adherent patients had threefold lower mortality than non-adherent ones. Hip and vertebral fractures had an increased death risk (p < 0.001) compared to wrist and/or humerus. AFT results in an effect modifier of the association between the site of FF and mortality risk (p = 0.003).
Source: ResultsAbstract: Conclusion
The implementation of an IHCP, based on a FLS integrated model, shows a tendency to improve FF management, especially among younger patients with humerus or wrist FF. We confirmed a lower mortality among subjects received appropriate AFT.
Source: ConclusionAuthors’ abstract
Summary
As the global population ages, osteoporosis and fragility fractures (FF) are emerging health concerns worldwide. This study assesses the effectiveness of an integrated hospital-community pathway in improving prescription and adherence to anti-fracture treatment. Additionally, it analyzes the re-fracture rate and mortality at a 24-month follow-up from an index FF.
Purpose
Evaluate the effectiveness of an integrated healthcare pathway (IHCP) on appropriateness and adherence to anti-fracture treatment (AFT) in adults aged ≥ 50 years, hospitalized due to fragility fracture (FF). Re-fractures and mortality rates were explored as secondary outcomes.
Methods
Subjects aged 50 years and more, resident in the province of Pavia, Italy, were enrolled at the time of hospital admission due to major FF, in the period 2016 to 2018 and 2019 to 2020 before and after the implementation of the IHCP, respectively. Data were extracted from the administrative database of the Health Protection Agency of Pavia, starting from the index event and until 24 months. Data analyses were conducted for the primary and secondary outcomes. Univariate and multivariate Cox regression models were fitted.
Results
Among 9186 participants (74.7% women), aged 78 years, 12.7% initiated an AFT, and half of them (6.3%) within 6 months after the index FF. Comparing pre: and post: IHCP implementation phases, the appropriateness of AFT initiation increased in subjects with index humerus/wrist FF, oral AFT prescription decreased, while subcutaneous or intravenous treatments increased (p < 0.001). Total adherence to AFT slightly increased. The re-fracture rate was 5.2 per 100 person/year, with age, IHCP implementation, and hip FF associated with a higher likelihood of refracture.
The mortality rate was 13.4 per 100 person/year, with age, male gender, IHCP, and hip fracture as independent risk factors. Appropriate AFT significantly reduced mortality compared to no treatment (HR 0.55), with one-year adherence showing the strongest benefit (HR 0.18). Adherent patients had threefold lower mortality than non-adherent ones. Hip and vertebral fractures had an increased death risk (p < 0.001) compared to wrist and/or humerus. AFT results in an effect modifier of the association between the site of FF and mortality risk (p = 0.003).
Conclusion
The implementation of an IHCP, based on a FLS integrated model, shows a tendency to improve FF management, especially among younger patients with humerus or wrist FF. We confirmed a lower mortality among subjects received appropriate AFT.
Supplementary Information
The online version contains supplementary material available at 10.1007/s11657-025-01642-0.
Publication and source details
Original title: Effectiveness of an integrated hospital-community care pathway for fragility fractures’ secondary prevention: the PROMOTER-II study
Laura Bogliolo; Silvia Grignaschi; Catherine Klersy; Pietro Perotti; Simona Dalle Carbonare; Silvia Balduzzi; Michela Milanesi; Giuseppe Giuffrè; Carmelinda Ruggiero; Maria Cristina Caffetti
Archives of Osteoporosis · 2025
© The Author(s) 20252025https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Università degli Studi di PerugiaOpen access funding provided by Università degli Studi di Perugia within the CRUI-CARE Agreement.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T01:08:32.658192+00:00
DOI: 10.1007/s11657-025-01642-0 · PMC12708766